Safety Policy Manual Policy No. 106
|
|
- Mitchell Parrish
- 8 years ago
- Views:
Transcription
1 Safety Policy Manual Policy No. 106 Policy: Hazardous Drugs (Including Chemotherapeutic) Page 1 of 11 APPLICATION NYU Langone Medical Center (NYULMC) PURPOSE To protect employees from exposure to hazardous drugs. To ensure all waste containing hazardous drugs is disposed of in accordance with federal, state and local governmental regulations. To comply with OSHA regulations. 1.0 DEFINITIONS POLICY AND GENERAL INFORMATION Hazardous Drugs (HDs) - For the purpose of this policy, HDs are drugs that pose a risk to healthcare providers during preparation, administration, or disposal, and that possess one or more of the following four characteristics: genotoxic carcinogenic teratogenic or known to cause fertility impairment known to exhibit serious organ or other toxic manifestations at low doses in experimental animals or treated patients See Appendix A for a list of commonly used HDs and Appendix B for the NYULMC 2013 Hazardous Medication List Tisch Hospital Main Campus. 2.0 RESPONSIBILITIES 2.1 Environmental Health and Safety (EH&S) is responsible for: developing the policy for the safe handling and disposal of HDs assisting departments in the development of departmental protocols evaluating the effectiveness of the policy managing the HD Waste Disposal Program Revised: September 20, 2013
2 Safety Policy Manual Policy No. 106 Policy: Hazardous Drugs (Including Chemotherapeutic) Page 2 of 11 providing assistance to departments as needed to resolve technical and other issues, such as assistance with training and in the selection of personal protective clothing and equipment 2.2 Departmental Heads, or their designees, are responsible for compliance with the Policy within their departments. Their responsibilities include, but are not limited to: ensuring that all employees who may be exposed to HDs receive an orientation which covers the known material outlined in this policy ensuring appropriate protective equipment and clothing is readily available in each work area and is used in accordance with this policy ensuring all HD containers are properly labeled ensuring that appropriately labeled hazardous waste containers are readily accessible in all areas where HDs are used developing any additional protocols needed to ensure departmental employees are adequately protected 2.3 Employees who work with HDs are responsible for: reading and complying with all applicable sections of this policy attending departmental training sessions notifying their supervisors of exposures, spills or other pertinent problems 3.0 DRUG PREPARATION Reconstitution of HDs is restricted to designated personnel and must be done in a biological safety cabinet (BSC). 3.1 Personal Protective Equipment (PPE) Powder-free nitrile gloves shall be used for preparation of HDs unless the drug manufacturer specifically stipulates that some other glove provides better protection. A double layer of gloves is substantially less permeable and should be used if double-gloving does not interfere with the technique. Because all gloves are to some extent permeable, and their permeability increases with time, they should be changed regularly (hourly is preferable) or immediately if they are torn or punctured. Revised: September 20, 2013
3 Safety Policy Manual Policy No. 106 Policy: Hazardous Drugs (Including Chemotherapeutic) Page 3 of A protective disposable gown made of lint-free low permeability material with a closed front, long sleeves and elastic or knit-closed cuffs, or equivalent protective clothing, shall be worn. The cuffs shall be tucked under the gloves. Gowns and gloves shall not be worn outside the preparation area All gowns, gloves, and other disposable materials that may be contaminated with HDs shall be disposed of in accordance with HD waste disposal procedures (see Section 6.0). 3.2 Preparation Area Warning signs, designating the area as a Hazardous Drug Preparation Area for authorized staff only, shall be posted. Spill procedures shall also be posted. Eating, drinking, smoking, chewing gum, applying cosmetics, and storing food in or near the preparation area are prohibited A Class II BSC shall be used for the preparation of HDs. The blower on the vertical airflow hood shall be on at all times, 24 hours a day, 7 days a week. BSCs shall be certified through the EH&S Certification and Maintenance Program at least annually and any time the cabinet is moved. Contact EH&S for information on certification and maintenance. 3.3 Preparation Equipment HDs shall be prepared in a BSC on a disposable, plastic-backed paper liner. The liner shall be changed after any overt spill and after each work shift All necessary items shall be placed within the BSC before work begins, and all extraneous items shall be kept out of the work area in order to avoid contamination Syringes must always be large enough so that they are never more than three-fourths full. A non-splash disposal collection vessel such as a plastic or metal tray lined with sterile gauze pads shall be at hand to collect excess solution A closable, puncture-resistant, shatter-proof container for disposal of contaminated sharp or breakable materials, including glass drug vials, shall be readily available in each preparation area Sealable plastic bags, such as wire tie or "zip-lock" bags, shall be at hand so that all contaminated materials (other than sharps), including gloves, Revised: September 20, 2013
4 Safety Policy Manual Policy No. 106 Policy: Hazardous Drugs (Including Chemotherapeutic) Page 4 of 11 drug vials and paper liners, can be immediately placed in them. Sealed waste bags shall be discarded in the black "Hazardous Waste" containers (see Section 6.0) The BSC shall be cleaned with 70% alcohol daily, whenever spills occur, and when the cabinet requires service or certification. Decontamination shall consist of surface cleaning with high ph agents, followed by thorough rinsing. Removable work trays, if present, shall be removed, and the back of the work tray and the sump below shall be included in the cleaning. 3.4 Work Practices during Preparation Proper aseptic techniques must be used The following special precautions are necessary for work in a BSC: Manipulations shall not be performed close to the work surface. Unsterilized items, including liners and hands, shall be kept downstream from the work area to prevent contamination of the drug All syringes, IV bags and bottles containing HDs shall be labeled with a distinctive warning label such as "Hazardous Drug -- dispose of properly." Syringes and IV Bags Vials Syringes and IV bags shall be labeled with patient's name and room number, drug name and quantity per total volume, route of administration, date prepared, dose, expiration date, and storage requirements if the drug is not to be administered immediately. Medication vials shall be vented only in a BSC, unless a hydrophobic filter-needle unit or other approved chemo dispensing pin type device is available to eliminate pressure. A sterile gauze shall be wrapped around the needle and vial top when withdrawing solution (employees should take care to avoid needle-sticks during this procedure). The drug shall be withdrawn from the vial while negative pressure is maintained. If this use of negative pressure is considered impossible, a syringe shall be filled with air equal to the volume of drug required, and the solution withdrawn by alternately injecting small amounts of air into the vial and withdrawing equal amounts of liquid until the required volume is withdrawn. The drug shall Revised: September 20, 2013
5 Safety Policy Manual Policy No. 106 Policy: Hazardous Drugs (Including Chemotherapeutic) Page 5 of 11 be cleared from the needle and hub of the syringe before withdrawing, to avoid spraying on withdrawal Ampules Any material remaining in the top of an ampule shall be tapped down into the ampule before it is opened. A sterile gauze pad shall be wrapped around the ampule neck before breaking the top to protect against cuts and to catch aerosolized material Needles To expel air, the needle shall be held vertically with the needle upwards; the syringe shall be tapped to allow air bubbles to rise to the top of the solution, and the air bubbles expelled into sterile gauze, not into the air. If there is no immediate access to HD disposal container, then gauze shall be placed into an appropriately labeled plastic bag Oral agents 4.0 DRUG ADMINISTRATION Unit dose packaging is preferred for oral hazardous drugs. Packaging shall be opened carefully, and touching the tablet or capsule should be avoided. Drugs shall be placed directly into a medicine cup for administration. All waste shall be discarded in the appropriate hazardous waste container. Any manipulation of oral drugs, such as crushing, breaking, or mixing tablets with food or fluids shall be performed in a biologic safety cabinet designed for hazardous drug preparation. 4.1 PPE Employees who administer HDs shall wear nitrile gloves and a gown if there is a potential for exposure. 4.2 Work Practices Hands shall be washed before putting on gloves. Gowns or gloves that become contaminated shall be changed immediately Infusion sets and pumps, which should have Luer-lock fittings, shall be watched for signs of leakage during use. In situations where tubing could leak, a plastic-backed absorbent pad shall be available. Revised: September 20, 2013
6 Safety Policy Manual Policy No. 106 Policy: Hazardous Drugs (Including Chemotherapeutic) Page 6 of 11 Revised: September 20, Where feasible, priming IV sets and expelling air from syringes shall be carried out in a BSC. If this is not feasible, gauze in a plastic bag shall be used as a receptacle. Syringes, IV bottles and bags, and pumps shall be wiped clean of any drug contamination Contaminated materials shall be discarded into a black "Hazardous Waste" container Hands shall be washed after removal of gloves. 5.0 CARING FOR PATIENTS RECEIVING HDs 5.1 PPE and Work Practices Personnel dealing with blood, vomitus, or excreta from patients who have received HDs in the previous 48 hours shall wear exam gloves and phlebotomists disposable gowns, to be discarded after each use into black Hazardous Waste" containers (see Section 6.0) Hands shall be washed after removal of gloves or after contact with the above substances. 5.2 Linen Linen contaminated with HDs, blood, vomitus, or excreta from a patient who has received HDs in the previous 48 hours shall be handled carefully to minimize the potential for aerosolization Building Service personnel shall wear protective gloves when handling contaminated linen in patient care areas Employees who work in the laundry room shall wear protective gloves and gowns when handling contaminated linen. 6.0 WASTE DISPOSAL Refer to NYULMC Safety Policy No. 108b: Drug and Chemical Waste from Patient Care. 7.0 SPILLS 7.1 General Procedures Spills and breakages shall be cleaned up immediately by trained personnel.
7 Safety Policy Manual Policy No. 106 Policy: Hazardous Drugs (Including Chemotherapeutic) Page 7 of Personnel must wear gloves regardless of the size of the spill. In addition, personnel shall wear gowns and eye protection when cleaning up spills EH&S must be contacted to clean up a spill if there is any danger of airborne powder or aerosol being generated. (A HEPA filtered respirator shall be worn during such clean ups, in accordance with Safety Policy No Respiratory Protection. 7.2 Chemotherapy Spills within the Oncology Nursing Areas For spills of chemotherapy drugs within the Oncology Nursing areas, refer to the NYU Hospitals Center Oncology Nursing Service Process Standard (Appendix C) for the required cleanup procedures to follow. 7.3 Clean Up of Small Spills Liquids shall be absorbed using plastic backed pads; powders shall be wiped with wet absorbent gauze. The spill areas shall then be cleaned with a detergent solution and rinsed twice with clean water. An appropriate NIOSH approved respirator shall be used, in accordance with Safety Policy No Respiratory Protection Program, for spills where airborne powder or aerosol has been generated Any broken glass fragments shall be placed in a small cardboard or plastic container and then into a black "Hazardous Waste" container along with all other contaminated waste Contaminated reusable items such as pumps shall be wiped dry at the point of contamination. The equipment shall then be cleaned as per standard protocol. 7.4 Cleanup of Large Spills EH&S must be contacted immediately Access to spill area shall be restricted The spread of the spill shall be limited by gently covering with absorbent sheets or spill-control pads or pillows or, if a powder is involved, with damp cloths or towels. Care shall be taken not to generate aerosols. An appropriate NIOSH approved respirator shall be used, in accordance with NYULMC Safety Policy No. 109: Respiratory Protection Program, for spills where airborne powder or aerosol has been generated. Most hazardous drugs are not volatile; however, this may not be true for all Revised: September 20, 2013
8 Safety Policy Manual Policy No. 106 Policy: Hazardous Drugs (Including Chemotherapeutic) Page 8 of 11 HDs. The volatility of the drug shall be assessed prior to selecting the type of respiratory protection An appropriately labeled hazardous waste container shall be brought to the spill site. After picking up the spill, all contaminated surfaces shall be thoroughly cleaned three times with detergent and water. All contaminated absorbents and other disposable materials shall be discarded into this container Contaminated reusable items shall be placed in a sealed plastic bag for transport to a sink. They shall be carefully washed with detergent by personnel wearing double gloves and other appropriate PPE. 7.5 Spills in BSCs After the above spill clean-up procedures have been followed, decontamination of all interior surfaces may be required. If the HEPA filter of a BSC is contaminated, the unit must be labeled "Do not use -- contaminated", and the filter changed and disposed of by the contractor used to service BSCs. Arrangements for decontamination may be made by contacting EH&S. 7.6 Spill Kits Spill kits shall be kept in or near preparation and administrative areas. Kits are available from EH&S. 8.0 PERSONNEL CONTAMINATION Overt contamination of gloves or gowns, or direct skin or eye contact shall be treated as follows: Immediately remove gloves and/or gown. For skin contact, wash the affected skin area with soap (not a germicidal cleaner) and water. For eye exposure, flush the affected eye with water or saline solution for at least 5 minutes. If contact lenses are in place, they should be removed prior to eye washing and should not be replaced into the eye. Report the incident to a supervisor and report to Employee Health Service or the Emergency Department in accordance with NYULMC Safety Policy No. 101: Employee Occupational Injury/Illness Reporting System. Revised: September 20, 2013
9 Safety Policy Manual Policy No. 106 Policy: Hazardous Drugs (Including Chemotherapeutic) Page 9 of STORAGE AND TRANSPORT 9.1 Storage Areas Access to areas where HDs are stored shall be limited to authorized personnel Storage areas shall be marked with a warning sign Where feasible, HDs shall be stored separately from other drugs Facilities shall be designed to prevent containers from falling or being damaged. 9.2 Receiving Damaged HD Packages Only personnel who have received hazard awareness training are permitted to handle damaged HD packages. Contact EH&S for assistance, if needed Damaged cartons shall only be opened in a BSC by an employee wearing the same protective equipment as is used in preparation (see Section 3.1) Broken containers and contaminated packaging shall be placed in a puncture-resistant receptacle, which shall then be placed in a black Hazardous Waste" container (see Section 6.0). 9.3 In-house Transportation HDs shall be securely capped or sealed and packaged in impervious packing material for transport Personnel involved in transporting HDs must be trained in the hazards of the drugs and the necessary procedures should a spill occur All HDs must be labeled with a warning label and clearly identified as hazardous INFORMATION AND TRAINING 10.1 Material Safety Data Sheets (MSDSs)/Safety Data Sheets (SDSs) The Pharmacy Department shall maintain MSDSs/SDSs for all HDs used at NYULMC MSDSs/SDSs shall be readily available to employees working with HDs. Revised: September 20, 2013
10 Safety Policy Manual Policy No. 106 Policy: Hazardous Drugs (Including Chemotherapeutic) Page 10 of Supervisors shall make MSDSs/SDSs available to employees upon request, in accordance with NYULMC Safety Policy No. 121: Hazard Communication Program Upon request, EH&S may assist with obtaining an MSDS/SDS Training and Personnel Each department shall be responsible for training all departmental employees involved in any aspect of the handling of HDs Training shall include information about the known risks of HDs, relevant techniques and procedures for handling, the proper use of protective equipment and materials, spill procedures, and medical policies Medical staff shall be informed of this policy and of the expectation that they will comply Upon request, EH&S may assist departments with training MEDICAL SURVEILLANCE 11.1 Medical staff potentially exposed to HDs shall be monitored to identify the earliest reversible biologic effects so that the exposure can be reduced or eliminated before the employee sustains irreversible damage. For detection and control of work-related health effects, job specific medical evaluations shall be performed: before job placement periodically during employment (every 1 to 3 years depending on exposure) following acute exposures at the time of job termination or transfer 11.2 Questions about medical surveillance should be directed to Employee Health Services. Revised: September 20, 2013
11 Safety Policy Manual Policy No. 106 Policy: Hazardous Drugs (Including Chemotherapeutic) Page 11 of RELATED SAFETY POLICIES Policy No. 101: Employee Occupational Injury/Illness Reporting System Policy No. 108b: Drug and Chemical Waste from Patient Care Policy No. 109: Respiratory Protection Program Policy No. 121: Hazard Communication Program Appendix A Appendix B Appendix C Sample List of Drugs that Should be Handled as Hazardous NYULMC 2013 Hazardous Medication List - Tisch Hospital Main Campus NYU Hospitals Center Oncology Nursing Service Process Standard Issue date 12/13 Replaces 11/11 Reviewed by J. Goldberg, Environmental Health & Safety P. Hughes, Nursing Education NYUHC Environment of Care Committee Revised: September 20, 2013
12 Revised: September 20, 2013 Safety Policy 106, Appendix A
13 Revised: September 20, 2013 Safety Policy 106, Appendix A
14 Revised: September 20, 2013 Safety Policy 106, Appendix A
15 Revised: September 20, 2013 Safety Policy 106, Appendix A
16 Revised: September 20, 2013 Safety Policy 106, Appendix A
17 Revised: September 20, 2013 Safety Policy 106, Appendix A
18 Safety Policy 106, Appendix B NYULMC 2013 Hazardous Medication List Tisch Hospital Main Campus Anti-Neoplastics Generic Name Brand Name Regulated Dosage Alemtuzumab Inj Campath Inj 30mg/ml Anastrozole Tab Arimidex Tab 1mg Arsenic Trioxide Inj Trisenox Inj 1mg/ml Asparaginase Erwinia Chrysanthemi Inj Erwinaze Inj 10,000 IU/ml Bendamustine Inj Treanda Inj 5mg/ml Bexarotene Tab Targretin 75mg Bicalutamide Tab Casodex Tab 50mg Bleomycin Inj Blenoxane Inj 3unit/ml Bortezomib Inj Velcade Inj 1mg/ml, 2.5mg/ml Brentuximab Inj Adectis 5mg/ml Busulfan Tab Myleran Tab 2mg Busulfan Inj Busulfex Ink 6mg/mL Cabazitaxel Inj Jevtana Inj 60mg/1.5ml Capecitabine Tab Xeloda Tab 500mg Carboplatin Inj Paraplatin Inj 10mg/ml Carfilzomib Inj Kyprolis Inj 2mg/ml Carmustine Implant Gliadel Implant 7.7mg Carmustine Inj BCNU Inj 3.3mg/ml Chlorambucil Tab Leukeran Tab 2mg, 4 mg CisPlatinum Inj Platinol Inj 1mg/ml Cladribine Inj Leustatin Inj 1mg/ml Clofarabine Inj Clolar 1mg/ml Cyclophosphamide Inj Cytoxan Inj 20mg/ml Cyclophosphamide Tab Cytoxan Tab 25mg, 50mg Cytarabine HCl Inj Cytosar Inj 20mg/ml, 100mg/ml Cytarabine Liposome Inj Depocyt Inj 10mg/ml Dacarbazine Inj DTIC Inj 10mg/ml Dactinomycin Inj Actinomycin D Inj 500mcg/ml Dasatinib Tab Sprycel Tab 50mg, 70mg, 100mg Daunorubicin Citrate Liposome Inj Daunoxome Inj 2mg/ml Daunorubicin Inj Cerubidine Inj 5mg/ml Decitabine Inj Dacogen Inj 5mg/ml Page 1 of 5
19 Safety Policy 106, Appendix B NYULMC 2013 Hazardous Medication List Tisch Hospital Main Campus Generic Name Brand Name Regulated Dosage Anti-Neoplastics Degarelix Inj Firmagon Inj 80mg, 120mg Denileukin Deftitox Inj Ontak Inj 150mcg/ml Docetaxel Inj Taxotere Inj 20mg/ml Doxorubicin Liposomal Inj Doxil Inj, Lipodox Inj 2mg/ml Doxorubicin Inj Adriamycin Inj 2mg/ml Doxorubicin powder Inj Adriamycin Inj 20mg Epirubicin Inj Ellence Inj 2mg/ml Eribulin Inj Halaven Inj 0.5mg/ml Erlotinib Tab Tarceva tab 100mg, 150mg Estramustine Cap Emcyt Cap 140mg Etoposide Cap VP-16 Cap 50mg Etoposide Inj VP-16 Inj 20mg/ml Everolimus Tab Afinitor Tab 2.5mg, 5mg Exemestane Tab Aromasin Tab 25mg Floxuridine Inj FUDR Inj 100mcg/ml Fludarabine Inj Fludara Inj 25mg/ml Fluorouracil Inj 5-FU Inj 50mg/mL Flutamide Cap Eulexin Cap 125mg, 250mg Fulvestrant inj Faslodex Inj 250mg Gemcitabine Inj Gemzar Inj 38mg/ml Goserelin Inj Zoladex 3.6mg, 10.8mg Hydroxyurea Cap Hydrea Cap 500 mg 500mg Idarubicin Inj Idamyicin Inj 1mg/mL Ifosfamide Inj Ifex Inj 50mg/ml Imatinib Cap Gleevec Cap 100mg, 400mg Interleukin-2 Inj Proleukin Inj 18 million units/ml Irinotecan HCl Inj Camptosar Inj 20mg/mL Ixabepilone Inj Ixempra Inj 2mg/ml Lenalidomide Tab Revlimid Tab 2.5mg, 10mg, 25mg Letrozole Tab Femara tab 2.5mg 3.75mg, 7.5 mg, Leuprolide Acetate Inj Lupron Depot Inj 11.25mg, 22.5mg, 30mg Page 2 of 5
20 Safety Policy 106, Appendix B NYULMC 2013 Hazardous Medication List Tisch Hospital Main Campus Generic Name Generic Name Generic Name Anti-Neoplastics Lomustine Cap CCNU Cap 10mg, 40mg,100 mg Mechlorethamine Inj Nitrogen Mustard Inj 10mg/ml Melphalan Tab Alkeran Tab 2mg Melphalan Inj Alkeran Tab 5mg/ml Mercaptopurine Tab Purinethol Tab 25mg, 50 mg Methotrexate Inj 25mg/ml Methotrexate Tab 2.5mg Mitomycin Inj Mutamycin Inj 0.5mg/ml Mitotane Tab Lysodren Tab 500mg, 1g, 2.5g Mitoxantrone Inj Novantrone Inj 2mg/mL Nelarabine Inj Arranon Inj 5mg/ml Nilotinib Cap Nilotinib Cap 150mg, 200mg Nilutamide Tab Nilandron Tab 150mg Oxaliplatin Inj Eloxatin Inj 5mg/ml Paclitaxel Inj Taxol Inj 6mg/mL Paclitaxel protein-bound Inj Abraxane Inj 5mg/ml Palatrexate Iinj Folotyn Inj 20mg/ml Pazopanib Tab Votrient Tab 200mg Pegaspargase Inj Oncaspar Inj 750 IU/ml Pemetrexed Inj Alimta Inj 500mg Pentostatin Inj Nipent Inj 2mg/ml Pralatrexate Inj Folotyn Inj 20mg/ml Procarbazine HCL Cap Matulane Cap 50 mg Romidepsin Inj Istodax Inj 10mg Sorafenib Tab Nexavar Tab 200mg Streptozocin Inj Zanosar Inj 1gm Sunitinib Tab Sutent Tab 12.5mg, 25 MG, 50 MG Tamoxifen Tab Nolvadex Tab 10mg Temozolamide Cap Temodar Cap 20mg, 100mg, 250 mg Temozolamide inj Temodar Inj 2.5mg/ml Temsirolimus Inj Torisel Inj 25mg/ml Thalidomide Cap Thalomid Cap 50mg, 100mg Page 3 of 5
21 Safety Policy 106, Appendix B NYULMC 2013 Hazardous Medication List Tisch Hospital Main Campus Generic Name Generic Name Generic Name Anti-Neoplastics Anti-Infectives Immunosuppressants Thioguanine Tab 6-TG Tab 40mg Thiotepa Inj Thioplex Inj 10mg/ml Topotecan Cap Hycamtin Cap 0.25mg, 1mg Topotecan Inj Hycamtin Inj 1mg/ml Tretinoin Cap ATRA 10mg Trastuzumab Emtansine Inj Kadcyla Inj 20mg/ml Tretinoin Cap ATRA Cap 10mg 3.75mg, 11.25mg, Triptorelen Inj Trelstar Inj 22.5mg Vinblastine Sulfate Inj Velban Inj 1mg/mL Vincristine Sulfate Inj Oncovin Inj 1mg/mL Vinorelbine Inj Navelbine Inj 10mg/mL Vorinostat Zolinza Cap 100mg Ziv-Aflibercept Inj Zaltrap Inj 25mg/mL Chloramphenicol Sod Succinate Inj Chloromycetin Inj 100mg/mL Cidofovir Inj Vistide Inj 75mg/mL Entecavir Tab Baraclude Tab 0.5mg, 1mg Ganciclovir Cap Cytovene Cap 250mg Ganciclovir Inj Cytovene Inj 50mg/ml Ribavirin Cap Rebetol Cap 200mg Ribavirin Soln Virazole Soln for Inh 20mg/mL Valganciclovir Tab Valcyte Tab 450mg Valganciclovir Susp Valcyte Susp 50mg/ml Zidovudine Cap Retrovir Cap 100mg Zidovudine Syrup Retrovir Syrup 10mg/mL Azathioprine Inj Imuran Inj 10 mg/ml Azathioprine Tab Imuran Tab 50mg,100mg,150mg Cyclosporine Cap Neoral Cap 25mg, 100mg Cyclosporine Inj Sandimmune Inj 50mg/mL Cyclosporine Oral Soln Sandimmune Oral Soln 100mg/mL Everolimus Tab Zortress Tab 0.25mg, 0.5mg, 0.75mg Page 4 of 5
22 Safety Policy 106, Appendix B NYULMC 2013 Hazardous Medication List Tisch Hospital Main Campus Generic Name Generic Name Generic Name Immunosuppressants Other Mycophenolate Delayed Release Tab Myfortic Tab 180mg, 360mg Mycophenolate Mofetil Cap Cellcept Cap 250mg, 1000mg Mycophenolate Mofetil Inj Cellcept Inj 33.3mg/mL Sirolimus Oral Soln Rapamune Oral Soln 1mg/mL Sirolimus Tab Rapamune Tab 0.5mg, 1mg, 2mg Tacrolimus Cap Prograf Cap 0.5mg 1mg Tacrolimus Inj Prograf Inj 5mg/mL Dutasteride Tab Avodart Tab 0.5mg Finasteride Tab Proscar Tab 5mg Misoprostol Tab Cytotec Tab 100mcg, 200mcg Zoledronic Acid Inj Zometa Inj 4mg/5mL References: NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings 2012: Polovich, M. (2011). Safe Handling of Hazardous Drugs. Pittsburgh, PA: Oncology Nursing Society. pp. 34, 37. Developed by: Paul Dantas, Pharm.D., Pharmacy Supervisor Man Yee Merl, Pharm.D., BCOP, Pharmacy Oncology Clinical Coordinator Page 5 of 5
23 Safety Policy 106, Appendix C NYU Hospitals Center Oncology Nursing Service Service Process Standard PROCEDURE FOR: Chemotherapy Spill Kit (Emergency Response Pack), Use of PURPOSE: their unit. To familiarize health care workers with procedures for safely managing chemotherapy spills on SUPPORTIVE DATA: 1. Chemotherapy drugs are administered in a variety of health care settings including the hospital and outpatient areas. Chemotherapy spills are handled following a standard cleanup procedure in all sites. 2. RNs /PCT s who have received instruction in using a spill kit, may clean a chemotherapy spills should the need arise. 3. The spill kit should be used for any spill on non-absorbable surfaces, or for any spill in a bed that involves linen. Double-bag the linen, and dispose of in a hazardous waste container. IF there is pooled or residual chemotherapy remaining on the mattress, this would require the use of a second chemotherapy spill kit. 5. See also Procedure Chemotherapy Disposal PROCEDURE 1. Take out all contents from the Chemotherapy Drug Spill Kit. Immediately post the sign that warns others of the presence of a hazardous spill. 2. Put on the gown, respirator, shoe coverings, safety glasses and both pairs of gloves. KEY POINTS The gloves in the kit may contain latex. If you are allergic to latex, you may substitute two pairs of nitrile gloves. 3. Lay absorbent pads over the spill, being careful not to create a splash. Avoid skin and eye contact with pads. (Do not rub or wipe area with the pad, as this increases the likelihood the pad will decompose and impede clean up.) 4. Detach the scoop from the scraper, and use both to pick up the gel. Place the contaminated gel in the leak proof waste bag. Pads will absorb the liquid and transform it into a gel to assist in disposal. Only use the absorbent pads provided in the spill kit to clean up the spill (Caution: The gel from the pads extremely slippery when wet.) For spills of >500 cc, more than one kit will be needed. If there is any broken glass, use the scoop to pick it up and place in the hazardous waste container in the dirty utility room. 5. Use spill towels, soap and water to pick up any remaining gel. Place towels in the leak proof bag. Seal the bag and place bag in another leak proof bag. For the moment, leave the outer bag open. Afterwards, call Building Services to mop up area using standard disinfectant. (Spill area should be cleaned thoroughly from least contaminated to most contaminated areas, using a detergent followed by clean water and repeat.) Page 1 of 3
24 Safety Policy 106, Appendix C 6. Remove personal protective equipment (PPE) in the following order and place in the unsealed bag: shoe coverings, then outer pair of gloves, followed by safety glasses and gown, and discard. Remove outer gloves before removing glasses so as not to contaminate face with gloves containing chemotherapy. 7. Seal the outer cytotoxic waste disposal bag, then remove inner gloves and discard in hazardous waste container. 8. Dispose of bag in the hazardous waste container in the dirty utility room. Contact Building Services to replace full hazardous waste containers. For spills at the CCC and Hassenfeld, dispose of bag in the hazardous waste container located in the Pharmacy. Page 2 of 3
25 Safety Policy 106, Appendix C REFERENCES: Polovich, M., Whiteford, J., Olsen M.(2009) Chemotherapy and Biotherapy Guidelines and Recommendations for Practice.3 rd Edition. ONS Publishing Division: Pittsburgh, PA. Sage Chemotherapy Drug Spill Kit: Instructions for Use: Crystal Lake, IL: Sage Products Inc.(?) DEVELOPED BY: P. Hughes MA, RN, BC, OCN R. Green, MSN, RN, OCN I. Tudman, MS A. Yood, MA APPROVED BY: Chair, Oncology Nursing Practice Council Senior Director of Nursing, Medical and Oncology Services DATE ISSUED: September 1997 REVIEW MONTH: September Revised September 2003 Revised February 2006 Revised January, 2012 DISTRIBUTION: Patient Care & Nursing Standards Website Page 3 of 3
INSTITUTIONAL POLICY AND PROCEDURE (IPP) Department: Manual: Section:
HOSPITAL NAME INSTITUTIONAL POLICY AND PROCEDURE (IPP) Department: Manual: Section: TITLE/DESCRIPTION POLICY NUMBER HANDLING OF H AZARDOUS DRUGS EFFECTIVE DATE REVIEW DUE REPLACES NUMBER NO. OF PAGES APPROVED
More informationChemotherapy Spill Response:
Chemotherapy Spill Response: Antineoplastic Spills Outside Of A Fume Hood Lisa Hudley, RN Training Coordinator Safety & Environmental Compliance William Guess Director Safety & Environmental Compliance
More informationEffective Date: 6/3/14
North Shore-Long Island Jewish Health System, Inc. Long Island Jewish Medical Center PATIENT CARE SERVICES POLICY TITLE: ORDERING, ADMINISTRATION AND DISPOSAL OF ORAL CHEMOTHERAPEUTIC AGENTS Prepared by:
More informationRecommendations for the Safe Use of Handling of Cytotoxic Drugs
Recommendations for the Safe Use of Handling of Cytotoxic Drugs Introduction Cytotoxic drugs are toxic compounds and are known to have carcinogenic, mutagenic and/or teratogenic potential. With direct
More informationThis course was written for RN.ORG by an outside consultant and RN.ORG has rights for distribution but is not responsible for the contents.
Safe Handling of Hazardous Drugs WWW.RN.ORG Reviewed September, 2015, Expires September, 2017 Provider Information and Specifics available on our Website Unauthorized Distribution Prohibited 2015 RN.ORG,
More informationSafe Handling of Cytotoxic Materials
Safe Handling of Cytotoxic Materials Kara Henman RN, MN, CON(C) Oncology Practice Consultant Cancer Care Nova Scotia What are hazardous drugs? Chemotherapy Immunosuppressive agents Biological agents Antiviral
More informationOncologic drug Exposure Risks and Prevention Guidelines 19 June 2014
Oncologic drug Exposure Risks and Prevention Guidelines 19 June 2014 ส งค กคามซ งอาจเป นอ นตรายต อส ขภาพ HAZARD? HAZARD ส งค กคามซ งอาจเป นอ นตรายต อส ขภาพ ENCLOSURE Substitution ส งค กคามซ งอาจเป นอ นตรายต
More informationTo provide direction for the safe handling, administration and disposal of hazardous drugs.
Subsection: MEDICATION Related terms: Cytotoxic Drugs, Antineoplastic Drugs Authorized by: Clinical Directors CS-04-02-01 Page 1 of 9 Date Established: October 2006 Date For Review: September 2014 Dates
More informationSAFE HANDLING OF HAZARDOUS MEDICATIONS. Cytotoxic and Non-Cytotoxic. Winnipeg Regional Health Authority Policy # 110.160.010
SAFE HANDLING OF HAZARDOUS MEDICATIONS Cytotoxic and Non-Cytotoxic Winnipeg Regional Health Authority Policy # 110.160.010 By the end of this presentation staff should be able to 1. Understand what information
More informationINTERDISCIPLINARY CLINICAL MANUAL Policy and Procedure
INTERDISCIPLINARY CLINICAL MANUAL Policy and Procedure TITLE: Safe Handling of Cytotoxic Drugs/Waste NUMBER: CC 05-055 Date Issued: August 2011 Page 1 of 11 Applies To: Holders of Interdisciplinary Clinical
More informationGROUP 1 CARCINOGEN, CHEMOTHERAPY WASTE & OTHER HAZARDOUS DRUG DISPOSAL NAME APPROVAL DATE EFFECTIVE DATE REVISION RENEE MICHEL 05/01/11 0
GROUP 1 CARCINOGEN, CHEMOTHERAPY WASTE & OTHER HAZARDOUS DRUG DISPOSAL NAME APPROVAL DATE EFFECTIVE DATE REVISION RENEE MICHEL 05/01/11 0 INTRODUCTION Prior to commencing work involving carcinogens, chemotherapeutics
More informationHydration, IV Infusions, Injections and Vaccine Charge Process
There are a number of items to be considered when billing for the Nursing service to perform drug therapy, the charge process is divided into three specific groups of codes and processes. 1. Hydration
More informationCytotoxic Agents Safe Management For Nursing Students. Pat Stalker Clinical Educator, LRCP Feb 2015
Cytotoxic Agents Safe Management For Nursing Students Pat Stalker Clinical Educator, LRCP Feb 2015 Overview and Objectives Review key content of the nursing procedure Differentiate between Hazardous drugs
More informationBill Mixon, RPh, MS Senior Associate Gates Healthcare Associates
Bill Mixon, RPh, MS Senior Associate Gates Healthcare Associates 14 pharmacists and 1 epidemiologist make up the committee USP staff FDA and CDC representatives have input but do not vote Call for Candidates
More informationBritish Columbia Cancer Agency
Page 1 of 8 RATIONALE To minimize the hazardous drug exposure of staff, patients and visitors to the BCCA Regional Centres, spills must be managed appropriately, according to established policies and procedures.
More informationMedications most likely to be seen in primary care
Hazardous Medicines The majority of medicines are not classed as hazardous. The only medicinal products that are automatically deemed to be hazardous are cytotoxic and cytostatic medicines. There is no
More informationREGIONAL. Applicable to all sites and facilities where the intended WRHA program services are delivered
REGIONAL Applicable to all sites and facilities where the intended WRHA program services are delivered Level: 1A Policy Name: Cytotoxic Agents, Safe Handling of Approval Signature: Policy Number: Section:
More informationMaryland Department of Health and Mental Hygiene 201 W. Preston Street Baltimore, Maryland 21201
STATE OF MARYLAND DHMH Maryland Department of Health and Mental Hygiene 201 W. Preston Street Baltimore, Maryland 21201 Martin O Malley, Governor Anthony G. Brown, Lt. Governor Joshua M. Sharfstein, M.D.,
More informationPolicies and Procedures. I.D. Number: 1044
Policies and Procedures Title: HAZARDOUS DRUGS (Non-Chemotherapy) ADMINISTRATION AND PRECAUTIONS I.D. Number: 1044 Authorization: [X] SHR Nursing Practice Committee Source: Nursing Date Revised: November
More informationMEDICAL CENTER ADMINISTRATIVE POLICY AND PROCEDURES SCOPE KFH Hospital, City Section No.
of 22 I. Purpose To establish safe medication practices for High Alert medications to maximize the safety of the medication processes associated with these medications. II. Policy. High alert medications
More information4729-16-11 Hazardous Drugs Compounded by a Prescriber.
ACTION: Original DATE: 11/30/2015 8:57 AM 4729-16-11 Hazardous Drugs Compounded by a Prescriber. (A) A facility where a prescriber is compounding or handling hazardous drugs shall be licensed as a terminal
More informationSafe Disposal Methods Management of Body Substances from Patients Undergoing and Following Cytotoxic Drug Therapy Background Hospital/ Institution Home Physician Nurse Nurse Aide Personnel handling waste
More informationTHE HAZARDOUS WASTE (ENGLAND AND WALES) REGULATIONS 2005
THE HAZARDOUS WASTE (ENGLAND AND WALES) REGULATIONS 2005 Interim Guidance for the NHS Hospital Sector for England and Wales and Information for Scotland Additional paper copies may be requested by contacting:
More informationResponse to Biological Spills in the Laboratory (Intentional or Accidental)
Response to Biological Spills in the Laboratory (Intentional or Accidental) Exposure Management For splash to eyes, mucous membranes, or broken area of the skin Irrigate eyes with clean water, saline or
More informationCarnegie Mellon University s Policy and Procedures for Recombinant and Synthetic Nucleic Acid Materials Spills
Carnegie Mellon University s Policy and Procedures for Recombinant and Synthetic Nucleic Acid Materials Spills Background In accordance with Section IV-B-2-b-(6) of the NIH Guidelines for Research Involving
More informationPreventing and Treating Nausea and Vomiting Caused by Cancer Treatment
A Patient s Guide Preventing and Treating Nausea and Vomiting Caused by Cancer Treatment Recommendations of the American Society of Clinical Oncology The American Society of Clinical Oncology (ASCO) is
More informationBLOODBORNE PATHOGENS EXPOSURE CONTROL PROGRAM
BLOODBORNE PATHOGENS EXPOSURE CONTROL PROGRAM Purpose: The purpose of this program is to eliminate or minimize employee and student exposure to blood and other potentially infectious materials. This exposure
More informationChapter 296-62-500, Part R Hazardous Drugs
Chapter 296-62-500, Part R Hazardous Drugs WAC 296-62-500 WAC 296-62-50005 WAC 296-62-50010 WAC 296-62-50015 WAC 296-62-50020 WAC 296-62-50025 WAC 296-62-50030 WAC 296-62-50035 WAC 296-62-50040 WAC 296-62-50045
More informationStandard Operating Procedure for Dacarbazine in Animals
Standard Operating Procedure for Dacarbazine in Animals 1. Health hazards Dacarbazine, also known as DTIC, DIC, and Imidazole Carboxamide, is an antineoplastic chemotherapy drug used in the treatment of
More informationChemotherapy: Safety Protocols. Janet Modrakovic, BAS, CVT
Chemotherapy: Safety Protocols Janet Modrakovic, BAS, CVT The word chemotherapy strikes fear in the heart of every pet owner whose beloved pet has been diagnosed with cancer. The incidence of cancer in
More informationBeware that ordinary prescription glasses do not provide adequate protection. This is also true with poorly fitting safety glasses.
Ethidium Bromide Introduction Ethidium bromide (EtBr) is widely used for visualization of nucleic acids in electrophoretic gels. EtBr forms fluorescent complexes, by intercalation of DNA, which are readily
More informationHazardous Precautions. Prepared By: Hazardous Precautions Working Group Updated: March 2014
Hazardous Precautions Prepared By: Hazardous Precautions Working Group Updated: March 2014 1 What are Hazardous Medications? They are therapeutic agents that are often used in the treatment of: cancer,
More informationBiosafety Guidelines. 5. Pipetting Mechanical pipetting devices must be available and used. Mouth pipetting is prohibited.
Biosafety Guidelines Biosafety Level 1 Laboratory Biosafety Level 1 is suitable for work involving well-characterized agents not known to consistently cause disease in immunocompetent adult humans, and
More informationMinimizing Occupational Exposure to Hazardous Chemicals in Animal Protocols
Environmental Health and Safety Minimizing Occupational Exposure to Hazardous Chemicals in Animal Protocols Chemicals that are highly toxic or corrosive, known or suspected carcinogens, reproductive hazards,
More information5:00 GUIDELINES FOR ORDERING, PREPARATION, DISPENSING, HANDLING, AND DISPOSAL OF
5:00 GUIDELINES FOR ORDERING, PREPARATION, DISPENSING, HANDLING AND DISPOSAL OF INTRAVENOUS AND HAZARDOUS DRUGS 5:01 Goals 5:02 Definitions 5:03 Hazardous Medication List 5:04 Personnel Requirements, Training
More informationBiosafety Level 2 (BSL-2) Safety Guidelines
BLS-4 Biosafety Level 2 (BSL-2) Safety Guidelines BSL-3 BSL-2 BSL-1 BSL-2 builds upon BSL-1. If you work in a lab that is designated a BSL-2, the microbes used pose moderate hazards to laboratory staff
More informationGuidelines for the Management of Spillage of Cytotoxic Drugs. No changes have been made as evidence base remains current.
Guidelines for the Management of Spillage of Cytotoxic Drugs Date Approved by Network Governance May 2012 Date for Review May 2015 Changes Between Versions 3.0 and 4.0 No changes have been made as evidence
More informationSummary of BCCA Pharmacy Practice Standards for Hazardous Drugs
Summary of BCCA Pharmacy Practice Standards for Hazardous Drugs Table of Contents Pharmacy Oncology Certification... 1 Module 1 Safe Handling of Hazardous Drugs... 1 Section A... 1 A.1 Potential Hazards
More informationSTANDARD OPERATING PROCEDURES SPILL RESPONSE AND CLEAN-UP OUTSIDE BIOSAFETY CABINET
BIOLOGICAL SPILL KIT IN A 5 GALLON BUCKET WITH LID Spill response and cleanup procedures (SOP) 1 Notepad 1 Pen 6 Business cards 1 Permanent marker 1 trash bag 6 Biohazard stickers 1 roll duct tape 1 roll
More informationManagement Plan For Control of Blood-borne Pathogens, Infectious Wastes and Other Potentially Hazardous Biological Agents
Management Plan For Control of Blood-borne Pathogens, Infectious Wastes and Other Potentially Hazardous Biological Agents 1.0 Executive Summary 1.1 The Bloodborne Pathogen standard, initiated by OSHA,
More informationCytotoxic and Biotherapies Credentialing Programme Module 6
Cytotoxic and Biotherapies Credentialing Programme Module 6 1. Safe Handling and Administration of Cytotoxic and Biotherapies 2. Waste and Spill Management At the completion of this module the RN will
More informationBLOODBORNE PATHOGENS EXPOSURE CONTROL PLAN
BLOODBORNE PATHOGENS EXPOSURE CONTROL PLAN Facility Name: University of Arkansas at Little Rock Date of Preparation: 01-17-06 In accordance with the OSHA Bloodborne Pathogens Standard, 1910.1030, the following
More informationBiological Safety Program
Risk Management & Safety Main Office, Wyoming Hall Phone: (307) 766-3277 Fax: (307)766-6116 Regulated Materials Management Center Phone: (307)766-3696 Fax: (307)766-3699 Web: www.uwyo.edu/ehs Email: UWEHS@uwyo.edu
More informationPI s Name Date Bldg./Rm# CDC Biosafety Level 3 (BSL-3)
PI s Name Date Bldg./Rm# CDC Biosafety Level 3 (BSL-3) Yes No 1. Is access to the laboratory limited or restricted at the discretion of the laboratory director when experiments are in progress? Yes No
More informationUNIVERSITY OF TOLEDO HEALTH SCIENCE CAMPUS
UNIVERSITY O TOLEO HEALTH SIENE AMPUS SUJET: HANLING O RUGS (H) Procedure No: HM-08-005 i.e., ANTINEOPLASTI AN ARINOGENI AGENTS PROEURE STATEMENT Hazardous drugs shall be handled in a manner so as to ensure
More informationInfectious Waste Management Plan
Infectious Waste Management Plan Infectious Waste Management Plan USC Health & Safety Programs Unit 777-5269 POLICY: A. In keeping with the University of South Carolina's policy of providing protection
More informationSafe Handling of Oral Chemotherapy and targeted Agents. ภญ.อภ รมย เหล าเจร ญเก ยรต ฝ ายเภส ชกรรม โรงพยาบาลศ ร ราช
Safe Handling of Oral Chemotherapy and targeted Agents. ภญ.อภ รมย เหล าเจร ญเก ยรต ฝ ายเภส ชกรรม โรงพยาบาลศ ร ราช Chemotherapy Agent. Low therapeutic index. -Increase risk for medication error. Hazardous
More informationAppendix J IBC Biohazard Spill Management Plan
OVERVIEW Prevention is the most important part of any spill management plan. Be sure to read and understand standard operating procedures (SOP s) and protocols for safe manipulation of biohazards before
More informationCOMPOUNDING WITH HAZARDOUS DRUGS
VOLUME 15 NUMBER 2 Secundum Artem Current & Practical Compounding Information for the Pharmacist. An ongoing CE Program provided by a grant from Paddock Laboratories, Inc. COMPOUNDING WITH HAZARDOUS DRUGS
More informationSPILLS & SPILL KITS. Spills -General Guidelines:
Spills -General Guidelines: If handled properly, a spill may be nothing more than a nuisance. If handled improperly, a spill can seriously disrupt your activities and the work of your colleagues. At worst,
More informationSpillage Waste Management
Spillage Waste Management Patient Information Introduction This leaflet contains the answers to some questions patients and carers may have about the disposal of chemotherapy waste and the management of
More informationParticularly Hazardous Substances (PHS) Standard Operating Procedure (SOP)
Particularly Hazardous Substances (PHS) Standard Operating Procedure (SOP) Formaldehyde, formalin, paraformaldehyde solutions, and paraformaldehyde solids Principal Investigator: Room & Building #: Department:
More informationBSL 1 Laboratory Biosafety Manual
BSL 1 Laboratory Biosafety Manual Version 1.0 Idaho State University, Office for Research Institutional Biosafety Committee (IBC) 1651 Alvin Ricken Drive, Pocatello, ID 83201-8046 Phone: 208-282-2179 Fax:
More informationHazards of Cytotoxic Drugs
38 H Y G E I A HYGEIA Vol.1, No.1 March-Aug, 09 Hazards of Cytotoxic Drugs 1 2 Kiron SS, Saritha M 1 Academy of Pharmaceutical Sciences, Medical College, Pariyaram, Kannur, Kerala. 2 Crescent College of
More informationBiosafety Spill Response Guide
Yale University Office of Environmental Health & Safety Biosafety Spill Response Guide Office of Environmental Health & Safety 135 College Street, 1 st Floor, New Haven, CT 06510 Telephone: 203-785-3550
More informationPromoting safer use of injectable medicines
Promoting safer use of injectable medicines A template standard operating procedure for: prescribing, preparing and administering injectable medicines in clinical areas Introduction The use of injectable
More informationBiosafety Level 2 Criteria
Biosafety Level 2 Criteria Biosafety in Microbiological and Biomedical Laboratories (BMBL) 5th Edition Biosafety Level 2 (BSL-2): Biosafety Level 2 builds upon BSL-1. BSL-2 is suitable for work involving
More informationHealth and safety practices for health-care personnel and waste workers
12 Health and safety practices for health-care personnel and waste workers 12.1 Principles Health-care waste management policies or plans should include provision for the continuous monitoring of workers
More informationThe Head of the Institute is to ensure that staff are working in safe environment and that the hierarchy of controls has been placed.
STANDARD OPERATING PROCEDURE SAFE HANDLING OF CYTOTOXIC DRUGS AND RELATED WASTE Kate Hill and Andrew Scuffham 2007; Reviewed by Els Acke, Jon Bray, and Steve Crow 2012 1 Purpose This Standard Operating
More informationCost Differences in Cancer Care Across Settings
Cost Differences in Cancer Care Across Settings August 2013 THE MORAN COMPANY 1 Cost Differences in Cancer Care Across Settings In a prior memorandum, we presented evidence documenting the growing share
More informationScott & White Institutional Biosafety Committee Compliance Program Biohazardous Material Spill Clean-Up Procedure Policy #IBC.002
I. Purpose Biohazardous material usage on the Scott & White campus is regulated by the Scott & White Institutional Biosafety Committee (IBC). Those investigators choosing to perform research with biohazardous
More informationTITLE: Storage and Management of Hazardous Medications & Chemicals APPLIES TO: Pharmacy Staff
Administrative Policies and Procedures for MOH hospitals /PHC Centers NO. OF PAGES: ORIGINAL DATE: REVISION DATE : 1.0 PURPOSE 1.1 To develop a set of safety rules and regulations that address the identification,
More informationOCCUPATIONAL SAFETY AND HEALTH ADMINISTRATION (OSHA)
OCCUPATIONAL SAFETY AND HEALTH ADMINISTRATION (OSHA) The OSHA/VOSH 1910.1030 Blood borne Pathogens Standard was issued to reduce the occupational transmission of infections caused by microorganisms sometimes
More informationCYTOTOXIC PRECAUTIONS A GUIDE FOR PATIENTS & FAMILIES
Perth and Smiths Falls District Hospital Attention: Manager, Quality 60 Cornelia Street, West Smiths Falls, Ontario K7A 2H9 CYTOTOXIC PRECAUTIONS A GUIDE FOR PATIENTS & FAMILIES This guide has been prepared
More informationGuidance sheet 4: Chemical Spill Management
Guidance sheet 4: Chemical Spill Management The purpose of this Guidance sheet is to provide information on how to prevent chemical spills and /or manage and respond to spills in the event that they do
More informationThe following standard practices, safety equipment, and facility requirements apply to BSL-1:
Section IV Laboratory Biosafety Level Criteria The essential elements of the four biosafety levels for activities involving infectious microorganisms and laboratory animals are summarized in Table 1 of
More informationTraining on Standard Operating Procedures for Health Care Waste Management Swaziland 12 May, 2011
Training on Standard Operating Procedures for Health Care Waste Management Swaziland 12 May, 2011 Safe Infectious Waste Handling and Transport Objective Waste Overview Roles and Responsibilities of Waste
More informationHazardous Drugs Spill Kit
Hazardous Drugs Spill Kit About the Joint Venture Baxter Pharmacy Services and CRG Healthcare have come together to produce the Hazardous Drugs Spill Kit Baxter Pharmacy Services Provides aseptically prepared
More informationSafe Operating Procedure
Safe Operating Procedure (Revised 12/11) SPILL AND EXPOSURE RESPONSE FOR BIOHAZARDOUS MATERIALS (INCLUDING RECOMBINANT NUCLEIC ACIDS) (For assistance, please contact EHS at (402) 472-4925, or visit our
More informationRE: Comments on USP 800 Hazardous Drugs Handling in Healthcare Settings
July 30, 2014 U.S. Pharmacopeial Convention RE: Comments on USP 800 Hazardous Drugs Handling in Healthcare Settings Submission via electronic means to CompoundingSL@usp.org The American Industrial Hygiene
More information6.0 Infectious Diseases Policy: Student Exposure Control Plan
6.0 Infectious Diseases Policy: Student Exposure Control Plan 6.1 PURPOSE & SCOPE This exposure control plan has been established to define the infection control program for students of Pacific University.
More informationStandard Operating Procedure for Blood Borne Infectious Disease Control Measures at Calvin College
Standard Operating Procedure for Blood Borne Infectious Disease Control Measures at Calvin College Clean up should be done by non-student employees and trained personnel only Cleaning Up BODY FLUIDS from
More informationBloodborne Pathogens. Updated 1.21.13
Bloodborne Pathogens Updated 1.21.13 Purpose OSHA s Blood-borne Pathogens Standard protects anyone with a job-related risk of contracting a blood-borne borne disease The standard outlines preventative
More information800 HAZARDOUS DRUGS HANDLING IN HEALTHCARE SETTINGS
BRIEFING 800 Hazardous Drugs Handling in Healthcare Settings. Because there is no existing USP chapter for this topic, the Compounding Expert Committee and the Compounding with Hazardous Drugs Expert Panel
More information1-800-862-2731 Administration of Meropenem For Child
1 Drug Name: _Meropenem 1-800-862-2731 Administration of Meropenem For Child Dosage: milligrams every hours over 5 minutes Key Points: FLUSHING: Meropenem Heparin flush 1. Always wash your hands with an
More informationClinical Waste Management & Sharps Injury Prevention. Clinical Skills
Clinical Skills Clinical Waste Management and Sharps Injury Prevention Clinical Skills and Simulation Team Cardiff and Vale Waste Management Team Aims & Outcomes Aims & Outcomes The aim of this module
More informationPharmaceutical Waste Program for Inpatient Pharmacy. Portland Service Area Pharmacy Leadership Team
Pharmaceutical Waste Program for Inpatient Pharmacy Portland Service Area Pharmacy Leadership Team What is Pharmaceutical Waste? Pharmaceutical waste is waste generated through IV preparation, compounding,
More informationSafe Handling of Hazardous Drugs
Safe Handling of Hazardous Drugs Staff Education May 1, 2015 Safe Handling of Hazardous Drugs Most hospitals have policies & procedures for the handling of cytotoxic drugs (chemotherapy) But what about
More informationClean Water: Supply side potable water, not wastewater. Gray Water/Sewage: Wastewater originating from a drain (sink, toilet, urinal).
Procedures for Emergency Responses to Flooding and Building Water Intrusion PURPOSE: To establish uniform, sanitary, and systematic procedures for responding to flooding and water intrusion emergencies.
More informationASHP Technical Assistance Bulletin on Handling Cytotoxic and Hazardous Drugs
Drug Distribution and Control: Preparation and Handling Technical Assistance Bulletins 49 ASHP Technical Assistance Bulletin on Handling Cytotoxic and Hazardous Drugs In 1985, the ASHP Technical Assistance
More informationOFFICIAL PUBLICATIONS. Hazardous Pharmaceuticals (Including Cytotoxic Drugs): Guidelines for Handling and Disposal (1997)
OFFICIAL PUBLICATIONS Hazardous Pharmaceuticals (Including Cytotoxic Drugs): Guidelines for Handling and Disposal (1997) Guidelines for Handling and Disposal Published by the Canadian Society of Hospital
More informationFLORENCE TOWNSHIP BOARD OF EDUCATION FILE CODE: 4112.4/4212.4 Florence, New Jersey
FLORENCE TOWNSHIP BOARD OF EDUCATION FILE CODE: 4112.4/4212.4 Florence, New Jersey Regulation Exposure Control Administration BLOODBORNE PATHOGENS A. The district safety and health program officer, district
More informationHow to safely collect blood samples from persons suspected to be infected with highly infectious blood-borne pathogens (e.g.
How to safely collect blood samples from persons suspected to be infected with highly infectious blood-borne pathogens (e.g. Ebola) Step 1: Before entering patient room, assemble all equipment (1 st part)
More informationSafe Work Procedure Sharps and Bio-hazardous waste handling and disposal
Safe Work Procedure Sharps and Bio-hazardous waste handling and disposal Task/Activity: Acupuncture and Musculoskeletal therapy (MST) clinics and practical classrooms (Acupuncture & MST Skin Infection
More informationLaboratory Biosafty In Molecular Biology and its levels
Laboratory Biosafty In Molecular Biology and its levels Workshop 16-17 Oct..2012 Guidelines Does not mean optional Laboratory Biosafety The Laboratory Biosafety Manual is an important WHO publication
More informationGUIDELINES FOR THE SAFE HANDLING OF CYTOTOXIC DRUGS AND RELATED WASTE
Occupational Safety and Health Information Series GUIDELINES FOR THE SAFE HANDLING OF CYTOTOXIC DRUGS AND RELATED WASTE OCCUPATIONAL SAFETY & HEALTH SERVICE LABOUR DEPARTMENT OF TE TARI MAHI Prepared by
More informationBloodborne Pathogens Program Revised July, 5 2012
Bloodborne Pathogens Program Revised July, 5 2012 Page 1 of 16 Table of Contents 1.0 INTRODUCTION...3 1.1 Purpose...3 1.2 Policy.3 2.0 EXPOSURE CONTROL METHODS 4 2.1 Universal Precautions.4 2.2 Engineering
More informationWhat is a hazardous drug? Hazardous Drugs: NIOSH. Pharmaceutical Waste: Hazardous pharmaceutical Waste 衛 福 部 疾 病 管 制 署
殘 餘 藥 物 之 處 置 衛 福 部 疾 病 管 制 署 中 區 傳 染 病 防 治 醫 療 網 王 任 賢 指 揮 官 What is a hazardous drug? ASHP 2004 TAB criteria for considering a drug hazardous (adopted by OSHA): 1. Carcinogenicity 2. Teratogenicity 3.
More informationCytotoxic Precautions at Home A Guide for Cancer Patients and Families
Cytotoxic Precautions at Home A Guide for Cancer Patients and Families Your cancer treatment... 1 What are cytotoxic precautions?... 1 What body fluids are cytotoxic?... 1 How do I handle my body wastes?...
More informationPOLICY & PROCEDURE: SAFE HANDLING OF SHARPS & NEEDLE STICKS
POLICY & PROCEDURE: SAFE HANDLING OF SHARPS & NEEDLE STICKS File Name: SAFESHARPSPP2013 Revision: 2 Date of Issue: Person Responsible: Edel Niland 1.0 POLICY Dublin Institute of Technology (DIT) endeavours
More informationAttachment D Infection Control Policy METHODS OF IMPLEMENTATION AND CONTROL
Attachment D Infection Control Policy METHODS OF IMPLEMENTATION AND CONTROL OSHA requires that the ECP include a schedule and method of implementation for the various requirements of the standard. The
More informationMOH Policy for dispensing NEOPLASTIC DISEASES DRUGS
MOH Policy for dispensing NEOPLASTIC DISEASES DRUGS All prescriptions for antineoplastic drugs must be accompanied by the MOH special form. All the attachments mentioned on this form shall be submitted
More informationThe proposed chapter is posted online at www.usp.org/usp-nf/notices/general-chapterhazardous-drugs-handling-healthcare-settings
BRIEFING 800 Hazardous Drugs Handling in Healthcare Settings, PF 40(3) [May Jun. 2013]. Based on the public comments received for the proposed 800 in PF 40(3), the USP Compounding Expert Committee has
More informationGeneral Guide to USP Proposed Chapter <800>: Hazardous Drugs Handling in Healthcare Settings
General Guide to USP Proposed Chapter : Hazardous Drugs Handling in Healthcare Settings DISCLAIMER: This general guide is not designed to be an all-inclusive review of USP . PCCA provides this
More informationBiohazard Response Spill Kit Frequently Asked Questions
Biohazard Response Spill Kit Frequently Asked Questions Q. Does the Biohazard Response Spill Kit remove a stain of blood from carpet that is a couple of days old or will it only work on fresh spills? Will
More informationHow To Understand And Understand The Rules Of Hazardous Waste
Understanding Regulated Medical Waste & Best Management Practices Regulations & References The information provided in this presentation is based on the referenced Code of Federal Regulations and State
More informationChemotherapy Drugs: How They Work
Chemotherapy Drugs: How They Work Chemotherapy is the use of any drug (such as aspirin or penicillin) to treat any disease. But to most people, chemotherapy refers to drugs used for cancer treatment. It
More informationCAG-005-2007 Servicing Hazardous Drug Compounding Primary Engineering Controls
CAG-005-2007 Servicing Hazardous Drug Compounding Primary Engineering Controls This document applies to hazardous drug (HD) compounding practice locations and is intended to provide guidance for service
More informationOESO Ergonomics Division...919-668-ERGO(3746) Duke Police...919-684-2444 Corporate Risk Management... 919-684-6226
Musculoskeletal Disorders (MSDs) Develop over time and can take a long time to heal Can be quite painful and reduce overall effectiveness and efficiency Occur in any part of the body A variety of risk
More information